# NVNO (enVVeno Medical Corporation) - SEC EDGAR Financial Statements

> enVVeno Medical Corporation reported $19.49M in total assets and a net loss of $15.55M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/NVNO
- Markdown: https://convexityos.com/fundamentals/NVNO.md
- SEC CIK: 0001661053
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001661053&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$16.41M | Operating profit |
| Net Income | FY 2025 | -$15.55M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$22.41 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$15.57M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $18.47M | Total debt: $408K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $31K | $187K | $422K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | $420K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $187K | $2.5K |
| Research & Development | $9.98M | $12.25M | $13.58M | $9.91M | $5.73M | $4.25M | $2.21M | $1.24M | $650K |
| Selling, General & Admin | $10.92M | $11.58M | $11.65M | $15.02M | $11.16M | $4.88M | $4.91M | $6.48M | $5.46M |
| **Operating Income** | -$20.90M | -$23.83M | -$25.24M | -$24.93M | -$16.89M | -$9.14M | -$7.68M | -$7.85M | -$6.10M |
| **EBITDA** | -$20.76M | -$23.64M | -$25.02M | -$24.72M | -$16.74M | -$9.04M | -$7.55M | -$7.72M | -$5.96M |
| Interest Income | $692K | $389K | $180K | $161K | -- | -- | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $305K | $173K |
| Income Before Tax | -$19.47M | -$21.82M | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$19.47M | -$21.82M | -$23.52M | -$24.67M | -$16.53M | -$9.14M | -$7.63M | -$13.04M | -$7.79M |
| Basic EPS | -$33.06 | -$44.53 | -$66.78 | -$76.92 | -$66.43 | -$263.64 | -$423.08 | -$1,529.72 | -$1,180.07 |
| **Diluted EPS** | -$33.06 | -$44.53 | -$66.78 | -$76.92 | -$66.43 | -$263.64 | -$423.08 | -$1,529.72 | -$1,180.07 |
| Basic Shares Outstanding | 589.0K | 490.0K | 351.8K | 321.2K | 248.2K | 36.9K | 18.0K | 10.7K | 7.0K |
| Diluted Shares Outstanding | 589.0K | 490.0K | 351.8K | 321.2K | 248.2K | 36.9K | 18.0K | 10.7K | 7.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.88M | $2.08M | $2.11M | $1.95M | $2.58M | $2.89M | $2.56M | $3.51M |
| Selling, General & Admin | $1.66M | $1.72M | $1.95M | $2.06M | $2.30M | $4.16M | $2.40M | $3.19M |
| **Operating Income** | -$4.53M | -$3.80M | -$4.06M | -$4.01M | -$4.88M | -$7.05M | -$4.95M | -$6.70M |
| **EBITDA** | -- | -- | -$4.03M | -$3.98M | -$4.85M | -$7.01M | -$4.91M | -$6.66M |
| Interest Income | $16K | $9.0K | $22K | $103K | $175K | $195K | $219K | $163K |
| **Net Income** | -$4.37M | -$3.60M | -$3.85M | -$3.74M | -$4.54M | -$6.69M | -$4.50M | -$6.23M |
| Basic EPS | -$6.29 | -$5.37 | -$5.89 | -- | -$7.89 | -$11.52 | -$7.75 | -- |
| **Diluted EPS** | -$6.29 | -$5.37 | -$5.89 | -- | -$7.89 | -$11.52 | -$7.75 | -- |
| Basic Shares Outstanding | 694.0K | 671.0K | 654.0K | -- | 575.0K | 581.0K | 581.0K | -- |
| Diluted Shares Outstanding | 694.0K | 671.0K | 654.0K | -- | 575.0K | 581.0K | 581.0K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.06M | $1.75M | $3.62M | $4.55M | $54.73M | $9.33M | $1.31M | $2.74M | $78K |
| Short-Term Investments | $25.15M | $41.40M | $42.79M | $34.49M | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $28.21M | $43.15M | $46.41M | $39.04M | $54.73M | $9.33M | $1.31M | $2.74M | $78K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $32K | $35K |
| **Total Current Assets** | $28.83M | $43.73M | $46.92M | $39.44M | $55.04M | $9.57M | $1.42M | $2.84M | $170K |
| Property, Plant & Equipment, Net | $51K | $182K | $334K | $521K | $618K | $399K | $344K | $26K | $24K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $666K | $1.11M |
| **Total Non-Current Assets** | $736K | $1.22M | $1.71M | $2.23M | $2.66M | $969K | $2.01M | $722K | $2.04M |
| **Total Assets** | $29.56M | $44.95M | $48.63M | $41.66M | $57.70M | $10.54M | $3.43M | $3.56M | $2.21M |
| Accounts Payable | $358K | $1.01M | -- | $1.22M | $560K | $1.39M | $1.22M | $1.08M | $1.45M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $33K | $33K | -- | $103K |
| **Total Current Liabilities** | $2.12M | $2.10M | $1.37M | $1.53M | $1.58M | $3.19M | $1.88M | $1.52M | -- |
| **Total Non-Current Liabilities** | $310K | $700K | $1.06M | $1.40M | $1.72M | $254K | $568K | $0 | -- |
| **Total Liabilities** | $2.43M | $2.79M | $2.44M | $2.93M | $3.29M | $3.44M | $2.44M | $1.52M | $8.17M |
| **Total Debt (incl. Leases)** | $700K | $1.06M | $1.40M | $1.72M | $2.01M | $568K | $857K | -- | -- |
| Common Stock | -- | -- | -- | -- | $95 | $25 | $7 | $117 | $61 |
| Retained Earnings | -$171.3M | -$151.9M | -$130.0M | -$106.5M | -$81.85M | -$65.32M | -$56.19M | -$48.56M | -$35.52M |
| **Total Stockholders' Equity** | $27.13M | $42.16M | $46.20M | $38.73M | $54.40M | $7.10M | $990K | $2.04M | -$11.13M |
| Total Equity | $27.13M | $42.16M | $46.20M | $38.73M | $54.40M | $7.10M | $990K | $2.04M | -$11.13M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.58M | $2.84M | $2.60M | $3.06M | $1.54M | $2.04M | $2.94M | $1.75M |
| Short-Term Investments | $15.89M | $18.64M | $22.33M | $25.15M | $29.41M | $33.10M | $36.00M | $41.40M |
| **Cash & Short-Term Investments** | $18.47M | $21.49M | $24.93M | $28.21M | $30.95M | $35.14M | $38.94M | $43.15M |
| **Total Current Assets** | $19.02M | $22.08M | $25.49M | $28.83M | $31.50M | $35.60M | $39.48M | $43.73M |
| Property, Plant & Equipment, Net | $62K | $78K | $16K | $51K | $82K | $113K | $142K | $182K |
| **Total Non-Current Assets** | $469K | $578K | $608K | $736K | $853K | $973K | $1.10M | $1.22M |
| **Total Assets** | $19.49M | $22.66M | $26.10M | $29.56M | $32.35M | $36.58M | $40.58M | $44.95M |
| Accounts Payable | $1.08M | $540K | $813K | $358K | -- | -- | -- | $1.01M |
| **Total Current Liabilities** | $2.59M | $1.89M | $2.14M | $2.12M | $2.40M | $3.02M | $1.66M | $2.10M |
| **Total Non-Current Liabilities** | $0 | $103K | $207K | $310K | $505K | $505K | $609K | $700K |
| **Total Liabilities** | $2.59M | $1.99M | $2.35M | $2.43M | $2.90M | $3.52M | $2.27M | $2.79M |
| **Total Debt (incl. Leases)** | $408K | $505K | $603K | $700K | $791K | $882K | $979K | $1.06M |
| Retained Earnings | -$183.1M | -$178.8M | -$175.2M | -$171.3M | -$167.6M | -$163.1M | -$156.4M | -$151.9M |
| **Total Stockholders' Equity** | $16.90M | $20.67M | $23.75M | $27.13M | $29.45M | $33.06M | $38.31M | $42.16M |
| Total Equity | $16.90M | $20.67M | $23.75M | $27.13M | $29.45M | $33.06M | $38.31M | $42.16M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$19.47M | -$21.82M | -$23.52M | -$24.67M | -$16.53M | -$9.14M | -$7.63M | -$13.04M | -$7.79M |
| Depreciation & Amortization | $136K | $189K | $220K | $212K | $149K | $98K | $124K | $133K | $139K |
| Stock-Based Compensation | $3.42M | $4.14M | $5.20M | $8.99M | $6.00M | $881K | $942K | $1.92M | $878K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $32K | $3.2K | -$12K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -- | $91K |
| Change in Payables | -- | -- | -$221K | $88K | -$833K | $169K | $144K | -$294K | $545K |
| **Operating Cash Flow** | -$15.57M | -$16.84M | -$18.86M | -$15.62M | -$11.85M | -$7.68M | -$5.90M | -$6.36M | -$4.20M |
| Capital Expenditure | -$5.0K | -$37K | -$33K | -$115K | -$368K | -$180K | -$364K | -$12K | -$11K |
| **Free Cash Flow** | -$15.57M | -$16.88M | -$18.89M | -$15.73M | -$12.22M | -$7.86M | -$6.26M | -$6.37M | -$4.21M |
| Purchases of Investments | -$46.02M | -$55.57M | -$56.52M | -$48.13M | -- | -- | -- | -- | -- |
| Sales & Maturities of Investments | $61.88M | $56.94M | $48.69M | $13.69M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $15.86M | $1.33M | -$7.87M | -$34.55M | -$368K | -$180K | -$364K | -$12K | $165K |
| Common Stock Issued | $782K | -- | $25.80M | -- | $57.36M | $12.23M | -- | -- | $1.29M |
| **Financing Cash Flow** | $1.02M | $13.64M | $25.79M | -- | $57.61M | $15.07M | $5.64M | $9.03M | $4.06M |
| **Net Change in Cash** | $1.31M | -$1.87M | -$935K | -$50.17M | $45.39M | $7.22M | -$623K | $2.66M | $21K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.37M | -$3.60M | -$3.85M | -$3.74M | -$4.54M | -$6.69M | -$4.50M | -$6.23M |
| Depreciation & Amortization | -- | -- | $31K | $31K | $31K | $34K | $40K | $40K |
| Stock-Based Compensation | $410K | $397K | $467K | $637K | $688K | $1.44M | $651K | $1.02M |
| **Operating Cash Flow** | -$3.18M | -$3.55M | -$3.24M | -$3.44M | -$4.39M | -$3.71M | -$4.02M | -$5.11M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -$4.0K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$5.11M |
| Purchases of Investments | -$15.84M | -$18.57M | -$22.24M | -$19.32M | -$9.89M | -$7.93M | -$8.87M | -$22.15M |
| Sales & Maturities of Investments | $18.58M | $22.24M | $25.01M | $23.50M | $13.55M | $10.76M | $14.07M | $11.10M |
| **Investing Cash Flow** | $2.73M | $3.67M | $2.77M | $4.18M | $3.65M | $2.82M | $5.20M | -$11.06M |
| **Financing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Change in Cash** | -$256K | $244K | -$468K | $1.52M | -$500K | -$893K | $1.18M | -$16.16M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 100.0% | 0.6% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -24566.5% | -4210.5% | -1445.9% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -24406.7% | -6991.5% | -1845.8% |
| Return on Equity (ROE) | -71.8% | -51.8% | -50.9% | -63.7% | -30.4% | -128.7% | -770.3% | -640.5% | -- |
| Return on Assets (ROA) | -65.9% | -48.5% | -48.4% | -59.2% | -28.6% | -86.7% | -222.0% | -366.4% | -351.8% |
| Current Ratio | 13.58x | 20.88x | 34.23x | 25.78x | 34.84x | 3.00x | 0.76x | 1.86x | -- |
| Quick Ratio | 13.30x | 20.60x | 33.85x | 25.52x | 34.64x | 2.93x | 0.70x | 1.82x | -- |
| Debt to Equity | 0.03x | 0.03x | 0.03x | 0.04x | 0.04x | 0.08x | 0.87x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -83.3% | -55.8% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | +7508.2% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -92.0% | -76.1% | -79.2% | -71.8% | -74.6% | -69.8% | -55.7% | -51.8% |
| Return on Assets (ROA) | -79.8% | -69.4% | -72.1% | -65.9% | -67.9% | -63.1% | -52.6% | -48.5% |
| Current Ratio | 7.35x | 11.70x | 11.89x | 13.58x | 13.12x | 11.81x | 23.77x | 20.88x |
| Quick Ratio | 7.13x | 11.39x | 11.63x | 13.30x | 12.90x | 11.66x | 23.44x | 20.60x |
| Debt to Equity | 0.02x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
